Breaking News - The Fly

Open Search

SPRO

Spero Therapeutics

$

()

Spero Therapeutics files $300M mixed securities shelf

SPRO

3/15/2024 - 16:40pm

Spero Therapeutics reports Q4 EPS (96c), consensus (10c)

SPRO

3/13/2024 - 16:06pm

Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call

INSM , SPRO , ANTX

…

3/5/2024 - 10:25am

Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call

INSM , SPRO , ANTX

…

3/5/2024 - 04:55am

Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call

INSM , SPRO , ANTX

…

3/1/2024 - 12:19pm

Spero Therapeutics announces clearance by U.S. FDA of IND for SPR206

SPRO

2/28/2024 - 08:12am

Spero Therapeutics expects cash to fund requirements into late 2025

SPRO

1/5/2024 - 08:19am

Spero Therapeutics provides 2024 anticipated milestones

SPRO

1/5/2024 - 08:19am

Spero announces first patient, first visit for Phase 3 PIVOT-PO trial

SPRO , GSK

1/2/2024 - 08:15am

Spero Therapeutics reports Q3 EPS (6c), consensus (3c)

SPRO

11/13/2023 - 16:07pm

Spero Therapeutics appoints Rajavelu as CFO, CBO

SPRO , FULC

11/1/2023 - 08:23am

Spero Therapeutics management to meet with Truist

SPRO

10/30/2023 - 04:55am

Spero Therapeutics management to meet with Truist

SPRO

10/23/2023 - 15:43pm

Spero Therapeutics price target raised to $7 from $6 at H.C. Wainwright

SPRO

8/14/2023 - 06:13am

Spero Therapeutics reports Q2 EPS (23c), consensus (34c)

SPRO

8/10/2023 - 16:36pm